Literature DB >> 8064244

Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor V beta 5-bearing CD8+ lymphocytes.

E Y Denkers1, P Caspar, A Sher.   

Abstract

To investigate early immune responses to the intracellular parasite Toxoplasma gondii, we examined the capacity of nonimmune splenocytes to respond in vitro to intact tachyzoites and soluble tachyzoite antigen (Ag). Both types of stimuli induced high levels of proliferation as well as interferon gamma (IFN-gamma) secretion. Based on several key criteria, the response appeared to be driven by a superantigen present in the parasite. Thus, stimulation of C57BL/6 spleen cells with T. gondii resulted in a preferential threefold expansion of a T cell population expressing the V beta 5 chain of the T cell receptor, and a survey of different inbred mouse strains revealed an inverse correlation between Ag-induced proliferation and genetic deletion of V beta 5. Moreover, proliferation was induced using irradiated Ag-pulsed and infected splenic adherent cells, and was blocked by a major histocompatibility complex class II-specific monoclonal antibody. Furthermore, paraformaldehyde-fixed IAb-, IAk-, and IEk-transfected fibroblast lines were able to specifically bind T. gondii Ag and drive proliferation of T lymphocytes, demonstrating that the response can be mediated by allogeneic class II molecules, and that it does not require cellular Ag processing. It is interesting to note that after 1 wk of culture with Ag, up to 70% of the expanded V beta 5-expressing cells were CD8+. These results provide the first description of a superantigen activity in a protozoan pathogen. In the case of T. gondii, superantigen-driven expansion of IFN-gamma-secreting CD8+ lymphocytes may play a role in the development of the dominant IFN-gamma-dependent, cell-mediated immunity characteristic of infection with this parasite.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064244      PMCID: PMC2191651          DOI: 10.1084/jem.180.3.985

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.

Authors:  T F Gajewski; F W Fitch
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

2.  Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.

Authors:  Y Suzuki; J S Remington
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

3.  Structure-function analysis of the Abm12 beta mutation using site-directed mutagenesis and DNA-mediated gene transfer.

Authors:  F Ronchese; M A Brown; R N Germain
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

4.  Immune responses associated with early survival after peroral infection with Toxoplasma gondii.

Authors:  R McLeod; P Eisenhauer; D Mack; C Brown; G Filice; G Spitalny
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

5.  Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.

Authors:  P Zanovello; E Vallerani; G Biasi; S Landolfo; D Collavo
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

6.  Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production.

Authors:  D J Fast; P M Schlievert; R D Nelson
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

7.  The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice.

Authors:  J White; A Herman; A M Pullen; R Kubo; J W Kappler; P Marrack
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

8.  Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.

Authors:  Y Suzuki; M A Orellana; R D Schreiber; J S Remington
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

9.  T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells.

Authors:  B Fleischer; H Schrezenmeier
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice.

Authors:  E Y Denkers; R T Gazzinelli; D Martin; A Sher
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  20 in total

1.  Toxoplasma gondii cyclophilin 18 regulates the proliferation and migration of murine macrophages and spleen cells.

Authors:  Hany M Ibrahim; Xuenan Xuan; Yoshifumi Nishikawa
Journal:  Clin Vaccine Immunol       Date:  2010-07-21

2.  Coinfection with Toxoplasma gondii inhibits antigen-specific Th2 immune responses, tissue inflammation, and parasitism in BALB/c mice infected with Leishmania major.

Authors:  H C Santiago; M A Oliveira; E A Bambirra; A M Faria; L C Afonso; L Q Vieira; R T Gazzinelli
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  An early intestinal mucosal source of gamma interferon is associated with resistance to and control of Cryptosporidium parvum infection in mice.

Authors:  Brett A Leav; Masaru Yoshida; Kathleen Rogers; Seth Cohen; Nihal Godiwala; Richard S Blumberg; Honorine Ward
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans.

Authors:  M B Purner; R L Berens; P B Nash; A van Linden; E Ross; C Kruse; E C Krug; T J Curiel
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Naive human alpha beta T cells respond to membrane-associated components of malaria-infected erythrocytes by proliferation and production of interferon-gamma.

Authors:  S Dick; M Waterfall; J Currie; A Maddy; E Riley
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

6.  Cellular immunity to Toxoplasma gondii in congenitally infected newborns and immunocompetent infected hosts.

Authors:  A F Fatoohi; G J N Cozon; M Wallon; S Kahi; F Gay-Andrieu; T Greenland; F Peyron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-04       Impact factor: 3.267

7.  Different roles for interleukin-4 during the course of Toxoplasma gondii infection.

Authors:  C W Roberts; D J Ferguson; H Jebbari; A Satoskar; H Bluethmann; J Alexander
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  Dynamics of the intracerebral and splenic cytokine mRNA production in Toxoplasma gondii-resistant and -susceptible congenic strains of mice.

Authors:  M Deckert-Schlüter; S Albrecht; H Hof; O D Wiestler; D Schlüter
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

9.  Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay.

Authors:  Emmanuelle Chapey; Martine Wallon; Gisèle Debize; Muriel Rabilloud; François Peyron
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

10.  A rapid flow cytometric method to explore cellular immunity against Toxoplasma gondii in humans.

Authors:  S Kahi; G J Cozon; T Greenland; M Wallon; F Gay-Andrieu; F Peyron
Journal:  Clin Diagn Lab Immunol       Date:  1998-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.